This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

LinkedIn to expand AI training to EU and UK, after backlash over automatic opt-ins

By Júlia Tar ( September 18, 2025, 16:45 GMT | Insight) -- LinkedIn will begin using user data from the EU, UK, Switzerland, Canada and Hong Kong to train its generative AI models from Nov. 3, reversing a 2024 policy that had excluded the European regions after regulators objected to the company’s automatic opt-in rollout in other markets. At the time, LinkedIn pledged to keep the EU, Switzerland and the UK outside the program “until further notice,” citing concerns about the EU's General Data Protection Regulation, but now says it will rely on the legitimate interest legal basis with an opt-out.LinkedIn will begin using user data from the EU, UK, Switzerland, Canada and Hong Kong to train its content-generating AI models from Nov. 3, according to updated terms of service. In Europe, the company says it will rely on the legitimate interest legal basis and is offering an opt-out....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login